Grant opportunity to develop innovative technology for oncology patients
NWO, KWF & Topsector LSH: Technology for Oncology II call
NWO Domain Applied and Engineering Sciences, The Dutch Cancer Foundation (KWF Kankerbestrijding) and the Dutch Topsector Life Sciences & Health (LSH) have jointly opened a new grant call: Technology for Oncology II. Via this call innovative research is funded to develop technology which is patient focused and targets a specific problem (future) cancer patients are facing.
Developing technology for cancer patients
This funding programme finances research, which aims at developing technology with a significant and identifiable impact on one or more of the mission goals of KWF Kankerbestrijding: less cancer, more cure and a better quality of life.
Main objectives of the Technology for Oncology II call
- (New) collaborations and technology transfer between Dutch technical universities or research groups with proven technical experience and other research institutes.
- Participation of, and collaboration with, industry in cancer-related technology development.
- Technology that can be used to improve prevention, diagnosis and/or treatment of cancer, including quality of life.
The primary focus of the research proposals should be the implementation and use of the obtained knowledge and results in oncology prevention, diagnosis, treatment and care.
Who can apply?
Funding can be requested by experienced researchers who hold a PhD and who are appointed at a Dutch university or a research institute recognized by NWO. Collaboration between at least two researchers from two disciplines (technology and oncology) and at least two private parties is required.
Application procedure and proposal budget
The deadline for full proposal submission is Thursday the 9th of May 2019. A typical project duration ranges from two to four years, with a maximum of four years. The maximum funding that can be requested for a partnership project is € 750,000. Full proposals will be assessed by (international) referees and by an independent committee on scientific quality and utilisation including the relevance for patients. The assessment committee will advise the NWO Domain AES and KWF Kankerbestrijding Board on which proposals should receive funding. The NWO Domain AES Board will decide in November 2019.
Criteria for applications
- Collaboration between Dutch technical universities or research groups with proven technical experience and Dutch non-technical research institutes with specific expertise in oncology is required.
- The involvement of at least 2 industrial partners is required.
- Co-funding of 15% of the project costs by private partners is required and can be brought together by several private partners.
- The application should meet the requirements to use PPP Allowance provided by Top Sector LSH with respect to substantive and financial reporting.
- Within the projects partnership specific agreements should be made with respect to intellectual property.
Are you curious to discover whether your research activities are connected to the Technology for Oncolgy II call? The specialists of Hezelburcht have broad experience with this type of applications and would be pleased to help and advice you.
Please contact us for more information!